Many ongoing implementation problems remain for this drug benefit program.
While beneficiary complaints about Medicare Part D have dropped substantially from May 1, 2006, through Oct. 31, 2007, many ongoing implementation problems remain for this drug benefit program. For instance, data gathered from plan sponsors do not paint a clear picture of whether beneficiaries who filed grievances were at risk of depleting their medications or whether plan sponsors were resolving complaints in a timely manner. These are some findings from a new report by the Government Accountability Office. GAO urged the Centers for Medicare and Medicaid Services to improve the way it collects grievances data, such as by enhancing the guidances it issues, requiring plan sponsors to report additional information, and other measures.